Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 5;16(3):361.
doi: 10.3390/pharmaceutics16030361.

Non-Invasive Device-Mediated Drug Delivery to the Brain across the Blood-Brain Barrier

Toshihiko Tashima  1 , Nicolas Tournier  2
Affiliations
Editorial

Non-Invasive Device-Mediated Drug Delivery to the Brain across the Blood-Brain Barrier

Toshihiko Tashima et al. Pharmaceutics. .

Abstract

We will be serving as the Guest Editor for this very interesting Special Issue on "Non-Invasive Device-Mediated Drug Delivery to the Brain Across the Blood-Brain Barrier" [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Profaci C.P., Munji R.N., Pulido R.S., Daneman R. The blood-brain barrier in health and disease: Important unanswered questions. J. Exp. Med. 2020;217:e20190062. doi: 10.1084/jem.20190062. - DOI - PMC - PubMed
    1. Ali A., Arshad M.S., Khan M.A., Chang M.W., Ahmad Z. Recent advances towards overcoming the blood–brain barrier. Drug Discov. Today. 2023;28:103735. doi: 10.1016/j.drudis.2023.103735. - DOI - PubMed
    1. Sasson E., Anzi S., Bell B., Yakovian O., Zorsky M., Deutsch U., Engelhardt B., Sherman E., Vatine G., Dzikowski R., et al. Nano-scale architecture of blood-brain barrier tight-junctions. eLife. 2021;10:e63253. doi: 10.7554/eLife.63253. - DOI - PMC - PubMed
    1. Catalano A., Iacopetta D., Ceramella J., Scumaci D., Giuzio F., Saturnino C., Aquaro S., Rosano C., Sinicropi M.S. Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies. Molecules. 2022;27:616. doi: 10.3390/molecules27030616. - DOI - PMC - PubMed
    1. Trejo-Lopez J.A., Yachnis A.T., Prokop S. Neuropathology of Alzheimer’s Disease. Neurotherapeutics. 2022;19:173–185. doi: 10.1007/s13311-021-01146-y. - DOI - PMC - PubMed

Publication types

LinkOut - more resources